Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yoshie Shudo"'
Small cell lung cancer (SCLC) is a highly malignant form of cancer, which originates from primitive neuroendocrine cells in the lung. SCLC cells express several autocrine neurotransmitters/neuropeptides and their respective receptors. Expression of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af46ea33b19193c9f663b0731cb5caf7
https://doi.org/10.1158/1541-7786.c.6539467
https://doi.org/10.1158/1541-7786.c.6539467
PDF - 202KB, Supplementary Figure 1: Growth curve for human SCLC cell lines growing on plastic or ECL extracellular matrix coated plastic dishes. Supplementary Table 1: Primers used for gene expression analysis. Supplementary Table 2: Comprehensive l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ab0155190cc18701e7dac944591ec76
https://doi.org/10.1158/1541-7786.22509979
https://doi.org/10.1158/1541-7786.22509979
Autor:
Masahito Shimojo, Takayasu Kurata, Satoshi Obika, Shin-ichi Tsunoda, Yuuya Kasahara, Yoshie Shudo, Masaki Inoue
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports
Scientific Reports
Small cell lung cancer (SCLC) is the most aggressive neuroendocrine phenotype of the deadliest human lung cancers. However the therapeutic landscape for SCLC has not changed in over 30 years. Effective treatment and prognosis are needed to combat thi
Publikováno v:
Life sciences. 143
Aims The pathophysiological mechanism for neuropathic pain (NP), one of the most common types of intractable pain, remains largely unknown. We previously reported that pituitary adenylate-cyclase activating polypeptide (PACAP) is required for the dev
Publikováno v:
Molecular cancer research : MCR. 11(10)
Small cell lung cancer (SCLC) is a highly malignant form of cancer, which originates from primitive neuroendocrine cells in the lung. SCLC cells express several autocrine neurotransmitters/neuropeptides and their respective receptors. Expression of t